Hexarelin, 5mg

Product Category

Growth Hormone Releasing Peptides (GHRP) & Cardioprotective Secretagogues

Action on the Human Body

Hexarelin (Examorelin) is a highly potent synthetic hexapeptide that acts as a selective agonist at the growth hormone secretagogue receptor (GHS-R1a) and binds distinctly to CD36 receptors on cardiac muscle cells. By targeting the pituitary gland and hypothalamus, Hexarelin delivers the strongest growth hormone (GH) pulse among all secretagogues, downregulating somatostatin to clear the way for extensive structural cell repair and fat tissue lipolysis. Crucially, its interaction with myocardial CD36 receptors preserves cardiac capillary integrity, protects heart tissue against ischemia-reperfusion injuries, improves left ventricular ejection fractions, and curbs post-injury myocardial remodeling.

What to Expect if Consumed

Users experience rapid changes in muscle hardness, major gains in strength, accelerated tendon/ligament healing, and robust physical endurance without the extreme appetite spikes common to lower-tier secretagogues.

Possible Therapy Combinations

Pairs exceptionally well with CJC-1295 No DAC to create the ultimate synergistic growth cascade, or layered with BPC-157 to maximize localized injury repair and soft-tissue regeneration.

Molecular Formula & Chemical Composition

Sequence: His-D-2-methyl-Trp-Ala-Trp-D-Phe-Lys-NH2. Molecular Formula: C47H58N12O6. Purity: >99% Pure Lyophilized Powder verified via strict HPLC analysis.

WARNING: This peptide compound must be handled and utilized exclusively under very high, correct professional and qualified medical supervision. Misuse can lead to unintended biological variations.

Scientific References

1. Imbimbo, B. P., et al. (1994). ‘Growth hormone-releasing activity of hexarelin in humans.’ Clinical Endocrinology.
2. Meloche, M., et al. (2026). ‘Cardioprotective effects of hexarelin acting via the CD36 receptor in models of ischemic heart disease.’ Journal of Cardiovascular Pharmacology.